Study Uncovers Mechanisms of Beta-Glucan’s Effect on Blood Cholesterol
Introduction to Beta-Glucan and Cholesterol
A recent study explored the mechanisms by which beta-glucan from barley influences blood cholesterol levels, also considering the role of genetic factors. There is increasing evidence that soluble dietary fiber plays a crucial role in preventing and managing cardiovascular diseases. Beta-glucan, a viscous water-soluble fiber found in cereals such as oats and barley, has garnered attention over the past two decades for its health benefits due to its functional and bioactive properties. While previous research has indicated that beta-glucan can lower blood cholesterol, the specific mechanisms behind this effect remain unclear.
Beta-Glucan and Cholesterol Metabolism
In humans, blood cholesterol levels are influenced by several factors, including cholesterol synthesis, dietary intake, absorption, and conversion to bile acids. The cholesterol-lowering effects of beta-glucan may arise from its impact on one or more of these metabolic pathways. Evidence suggests that beta-glucan binds to bile acids in the intestine, reducing their reabsorption and subsequently lowering liver bile acid levels. This process activates the enzyme cholesterol 7-alpha hydroxylase (CYP7A1), which facilitates the conversion of cholesterol into bile acids, leading to a reduction in overall cholesterol levels.
Research Methodology
A recent study published in the British Journal of Nutrition investigated the mechanisms by which beta-glucan lowers blood cholesterol and examined whether genetic differences in the CYP7A1 enzyme affect individual responses to beta-glucan. Conducted by Wang and colleagues at the University of Manitoba, Winnipeg, the randomized, single-blinded, diet-controlled, crossover trial included thirty participants who consumed barley diets with varying amounts of high and low molecular weight beta-glucan, as well as a control diet, over five weeks. Researchers measured serum lipids, cholesterol absorption, cholesterol biosynthesis, bile acid biosynthesis, and the CYP7A1 genotype at regular intervals during the study.
Effects of Beta-Glucan on Cholesterol Levels
After five weeks, participants who consumed 3 grams of high molecular weight beta-glucan daily exhibited lower total cholesterol levels compared to those on the control diet. In contrast, low molecular weight beta-glucan (both 3 grams and 5 grams) did not affect cholesterol absorption. The study revealed a significant genetic influence among participants consuming high molecular weight beta-glucan; specifically, cholesterol-lowering effects were observed only in individuals with a specific variant of the CYP7A1 gene. This suggests that genetic variation in the CYP7A1 enzyme may explain differing responses to beta-glucan’s cholesterol-lowering effects. Additionally, cholesterol absorption and synthesis remained unchanged across all CYP7A1 genotypes, while 3 grams of high molecular weight beta-glucan increased bile acid synthesis, with no effect observed from low molecular weight beta-glucan.
Beta-Glucan, Bile Acid Synthesis, and Cholesterol Levels
Bile acids, which are synthesized from cholesterol and secreted into the intestines, are affected by beta-glucan’s viscosity. The high viscosity of beta-glucan acts as a bile acid sequestering agent in the small intestine, preventing reabsorption into the bloodstream. Consequently, this leads to an increase in bile acid synthesis from cholesterol to replenish the bile acid pool, ultimately resulting in lower cholesterol levels. The study found a linear relationship between beta-glucan viscosity and bile acid synthesis, with no impact on cholesterol synthesis or absorption. These findings suggest that the interruption of bile acid circulation is the primary mechanism through which beta-glucan reduces blood cholesterol levels.
Conclusion and Future Research Directions
While the study provides valuable insights into the relationship between beta-glucan and cholesterol levels, it is limited by its small sample size. Researchers recommend that future studies involve larger cohorts to validate these findings. In conclusion, the research highlights that 3 grams of high molecular weight beta-glucan can effectively lower cholesterol levels by enhancing bile acid synthesis rather than affecting cholesterol synthesis or absorption. Furthermore, individual genetic differences play a significant role in the response to beta-glucan consumption. If corroborated by additional studies, these findings may have important implications for personalized nutrition strategies aimed at lowering blood cholesterol levels.
Written by Preeti Paul, MS Biochemistry
Reference: Yanan Wang et al., Barley beta-glucan reduces blood cholesterol levels via interrupting bile acid metabolism. British Journal of Nutrition, September 2017.